As a leading funder of innovation, we recognize the importance of integrating sustainability-related principles into our strategies and investments.

Accelerating innovation

We play an important role in accelerating innovation in life sciences and transforming patient lives

Donated and pledged to non-profits focused on underserved communities
Diseases addressed in our portfolio as of April 2024
of therapies address diseases on 2022 Access to Medicine Index
Social bonds issued

Through our policies and practices, designed to minimize our sustainability-related risk, we uphold our commitments to our partners and other stakeholders.

Pablo Legorreta,
Founder and Chief Executive Officer

Our approach

Royalty Pharma is committed to expanding our sustainable development strategy

Aligning to the United Nations (UN) Sustainable Development Goals (SDGs)

Our efforts are closely aligned to four of the United Nations Sustainable Development Goals (UNSDGs), where we believe we can have the greatest impact, based on our business, strategy and expertise.

Investing responsibly

Our comprehensive approach to responsible investment has been sharpened over 25+ years. We promote responsible practices through our investment process, partner selection and due diligence.

Engaging with our stakeholders

As part of our materiality assessment, we conducted a range of stakeholder surveys, interviews and workshops, alongside wider analysis and industry research, to help identify the key areas of focus for our business to prioritize sustainability issues.

Business oversight

Business oversight

Creating sustainable long-term value for our company, employees, shareholders and other stakeholders.

Supporting our talent

Developing a supportive and values-based culture that elevates our employees’ health, well-being and growth.

Supporting our communities

We aim to give back to the communities where we live and work, as well as help to provide the funds and resources required to address the healthcare challenges of a complex and evolving world.

Find out more

Stay up to date

Subscribe to Royalty Pharma news and alerts